K162613 is an FDA 510(k) clearance for the Integrated Catch-up Freedom Syringe Driver Infusion System. Classified as Pump, Infusion (product code FRN), Class II - Special Controls.
Submitted by Repro-Med Systems, Inc. Dba Rms Medical Products (New York, US). The FDA issued a Cleared decision on August 31, 2017 after a review of 346 days - an unusually long review period, suggesting complex equivalence evaluation.
This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5725 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.
Device pattern: Standard predicate-based submission. Elevated predicate reliance profile. This clearance follows a standard predicate-based equivalence path within the General Hospital review framework, consistent with the majority of Class II 510(k) submissions.